The FDA’s final regulations for OTC hearing aids appear to be at or near the publication stage. According to an online post by the Office of Information and Regulatory Affairs (OIRA), the review of the US Food and Drug Administration’s (FDA) final proposed rules for over-the-counter (OTC) hearing aids was completed by the Office of Management and Budget (OMB) on August 5....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change yet at this stage — this article reports a procedural OMB clearance step, not the final rule publication; clinicians should monitor for the actual rule release.
OMB clearance is the last federal hurdle before OTC hearing aid rules become law, making this a critical regulatory signal for the entire audiology profession.
- 01FDA's OTC hearing aid final rules passed the OMB (Office of Management and Budget) review stage.
- 02OMB clearance is typically the final step before a federal rule is officially published.
- 03The update was sourced from an OIRA (regulatory affairs office) online posting, not a formal FDA announcement.
- 04OTC hearing aids would allow adults to purchase amplification devices without a professional visit.
- 05The development has major implications for clinic revenue models and patient access.
The FDA's final OTC hearing aid rules advanced through the OMB review stage, signaling imminent publication.
press releasesupported
